Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children
Crossref DOI link: https://doi.org/10.1007/s00535-017-1406-2
Published Online: 2017-11-07
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kusano, Chika
Gotoda, Takuji
Suzuki, Sho
Ikehara, Hisatomo
Moriyama, Mitsuhiko
License valid from 2017-11-07